Показано 0 из 0
Дата |
---|
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
19.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
|
0.065
|
0.065
|
0.065
|
|
|
1 019.79
|
|
|
|
|
0.06
|
0.06
|
0.06
|
|
|
26.70
|
|
|
|
|
0.06
|
0.06
|
0.06
|
|
|
3 264.00
|
|
|
|
|
0.067
|
0.07
|
0.067
|
|
|
9 453.63
|
|
|
|
|
0.07
|
0.073
|
0.07
|
|
|
3 557.61
|
|
|
|
|
0.072
|
0.072
|
0.072
|
|
|
4 920.84
|
|
|
|
|
0.07
|
0.076
|
0.076
|
|
|
11 011.64
|
|
|
|
|
0.071
|
0.075
|
0.074
|
|
|
4 066.67
|
|
|
|
|
0.07
|
0.071
|
0.07
|
|
|
4 155.76
|
|
|
|
|
0.07
|
0.072
|
0.071
|
|
|
22 212.71
|
|
Invex Therapeutics Ltd operates as a biotechnology company. The Company offers therapeutics to treat diseases caused by raised intracranial pressure, neurological conditions, idiopathic intracranial hypertension, and raumatic brain injury. Invex Therapeutics serves patients in Australia.